BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34051744)

  • 21. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients.
    Ryan M; Crow J; Kahmke R; Fisher SR; Su Z; Lee WT
    Am J Otolaryngol; 2014; 35(6):689-94. PubMed ID: 25212103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; Cappelli K; Menchetti L; Silvestri S; Sforna M; Mecocci S; Iussich S; Leonardi L; Mechelli L
    Vet Pathol; 2021 Jan; 58(1):42-52. PubMed ID: 33021155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
    Wells G; Kennedy PT; Dahal LN
    Front Immunol; 2021; 12():651687. PubMed ID: 33777052
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
    Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
    Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
    Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
    J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.
    Wang H; Xia Y; Yu J; Guan H; Wu Z; Ban D; Wang M
    HLA; 2019 Jul; 94(1):39-48. PubMed ID: 30953385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
    Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
    Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
    Sharma MD; Hou DY; Liu Y; Koni PA; Metz R; Chandler P; Mellor AL; He Y; Munn DH
    Blood; 2009 Jun; 113(24):6102-11. PubMed ID: 19366986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
    Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
    J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
    Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
    Front Immunol; 2020; 11():120. PubMed ID: 32117271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients.
    Brocard A; Knol AC; Bossard C; Denis MG; Quéreux G; Saint-Jean M; Peuvrel L; Khammari A; Blancho G; Dantal J; Dréno B
    Acta Derm Venereol; 2017 Apr; 97(4):483-488. PubMed ID: 27868139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDO recruits Tregs in melanoma.
    Prendergast GC; Metz R; Muller AJ
    Cell Cycle; 2009 Jun; 8(12):1818-9. PubMed ID: 19471123
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?
    Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.
    Iga N; Otsuka A; Hirata M; Kataoka TR; Irie H; Nakashima C; Matsushita S; Uchi H; Yamamoto Y; Funakoshi T; Fujisawa Y; Yoshino K; Fujimura T; Hata H; Ishida Y; Kabashima K
    Cancer Sci; 2019 Nov; 110(11):3434-3441. PubMed ID: 31509303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
    Leslie C; Bowyer SE; White A; Grieu-Iacopetta F; Trevenen M; Iacopetta B; Amanuel B; Millward M
    Pathology; 2015 Oct; 47(6):557-63. PubMed ID: 26308130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.
    Mansfield AS; Heikkila PS; Vaara AT; von Smitten KA; Vakkila JM; Leidenius MH
    BMC Cancer; 2009 Jul; 9():231. PubMed ID: 19604349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
    Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
    Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.